Peter C. Gonze has been appointed executive vice president of Global Business Development at Averion International Corp. In this role, he will oversee the company’s global business development and marketing activities, and will serve on the company’s executive management team.
   
“Peter brings the necessary sales, marketing and operational management experience to grow Averion’s global sales. We will continue to pursue new business opportunities in North America and Europe, and plan to expand our geographic and therapeutic capabilities in emerging regions of the world,” said Dr. Markus H. Weissbach, chief executive officer of Averion International. “I welcome Peter to our senior management team and look to him to lead our sales growth and position Averion as a top-tier international CRO.”
   
Mr. Gonze has more than 35 years of pharmaceutical sales, marketing and development experience. He also has extensive leadership experience developing and commercializing products at biotech, pharmaceutical, device and consumer healthcare companies. Most recently, Mr. Gonze was the chief operating officer at Unither Pharmacueticals, a company focused on immunotherapeutic vaccines for oncology indications. He has broad experience in all aspects of commercial operations having held senior level positions in business development, commercial operations and general management with pharmaceutical and biotech companies including: GlaxoSmithKline, Rhône-Poulenc Rorer (now Sanofi-Aventis), Johnson & Johnson, Abbott Diagnostics-Medisense, and AltaRex.

News from our sister sites